Mr Lloyd E Glynn, RPH in Arbor Vitae, WI - Pharmacist

Mr Lloyd E Glynn, RPH is a Pharmacist based in Arbor Vitae, Wisconsin. Mr Lloyd E Glynn is licensed to practice in Wisconsin (license number 9546-40) and his current practice location is 2777 Downda Rd, Arbor Vitae, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (715) 356-6696.

NPI number for Mr Lloyd E Glynn is 1245344779 and his current mailing address is 2777 Downda Rd, Arbor Vitae, Wisconsin. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1245344779.

Contact Information

	Mr Lloyd E Glynn, RPH
	2777 Downda Rd, Arbor Vitae, WI 54568-9449
	(715) 356-6696
	Not Available

Healthcare Provider's Profile

Full Name	Mr Lloyd E Glynn
Gender	Male
Speciality	Pharmacist
Location	2777 Downda Rd, Arbor Vitae, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1245344779
Provider Enumeration Date: 08/19/2006
Last Update Date: 03/10/2020

Medical Identifiers

Medical identifiers for Mr Lloyd E Glynn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245344779	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	9546040 (Wisconsin)	Secondary
183500000X	Pharmacist	9546-40 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Lloyd E Glynn is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Lloyd E Glynn, RPH 2777 Downda Rd, Arbor Vitae, WI 54568-9449 Ph: (715) 356-6696	Mr Lloyd E Glynn, RPH 2777 Downda Rd, Arbor Vitae, WI 54568-9449 Ph: (715) 356-6696

News Archive

SQI enters clinical validation agreement with University North Carolina Kidney Center for Vasculitis Assay

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced it entered into a clinical validation agreement with University North Carolina Kidney Center, Chapel Hill, to evaluate SQI's new multiplexed, automated approach for biomarker detection in vasculitis.

Alcohol statistics in Australia: Beer low wine high

New statistics from the Australian Bureau of Statistic (ABS) on alcohol and wine consumption released on Tuesday show beer consumption is now at its lowest level in 61 years. It is making up less than half of all the pure alcohol consumed in Australia.

Suicide by opioid: New research suggests overdoses should be classified as self-harm

There has been a steady stream of headlines declaring that life expectancy in the United States is decreasing.

Advances in plant-made vaccines revive interest in plant-produced pharmaceuticals and edible drugs

Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).

Mr Lloyd E Glynn, RPH - Pharmacist in Arbor Vitae, WI